Identification of mitochondria-related action targets of quercetin in melanoma cells

References

• Babcock DF, Hille B. 1998. Mitochondrial oversight of cellular Ca2+ signaling. Curr Opin Neurobiol. 8(3):398–404. doi:10.1016/s0959-4388(98)80067-6.
   PubMed Web of Science ®Google Scholar
• Borghi SM, Pinho-Ribeiro FA, Fattori V, Bussmann AJC, Vignoli JA, Camilios-Neto D, Casagrande R, Verri WA. 2016. Quercetin inhibits peripheral and spinal cord nociceptive mechanisms to reduce intense acute swimming-induced muscle pain in mice. PLOS One. 11(9):e0162267. doi:10.1371/journal.pone.0162267.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang M, Zou H, Aniagu S, Jiang Y, Chen T. 2023. PM2.5 induces mitochondrial dysfunction via AHR-mediated cyp1a1 overexpression during zebrafish heart development. Toxicology. 487:153466. doi:10.1016/j.tox.2023.153466.
   PubMed Web of Science ®Google Scholar
• Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC. 2002. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62:6674–6681.
   PubMed Web of Science ®Google Scholar
• Ju YS, Alexandrov L, Gerstung M, Martincorena I, Stratton M, Campbell PJ. 2014. The landscape of mitochondrial DNA mutations in human cancer. Cancer Res. 74(19 Suppl.):4322. doi:10.1158/1538-7445.AM2014-4322.
   Google Scholar
• Lim S-K, Choi YW, Lim IK, Park TJ. 2012. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin Exp Metastasis. 29(8):901–913. doi:10.1007/s10585-012-9479-z.
   PubMed Web of Science ®Google Scholar
• Lin XY, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. 2006. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet. 15(13):2087–2097. doi:10.1093/hmg/ddl132.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Xu R-h, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, et al. 2006. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol. 175(6):913–923. doi:10.1083/jcb.200512100.
   PubMed Web of Science ®Google Scholar
• Reyes-Farias M, Carrasco-Pozo C. 2019. The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci. 20(13):3177. doi:10.3390/ijms20133177.
   PubMed Web of Science ®Google Scholar
• Rustin P. 2002. Mitochondria, from cell death to proliferation. Nat Genet. 30(4):352–353. doi:10.1038/ng0402-352.
   PubMed Web of Science ®Google Scholar
• Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. 2021. Epidemiology of melanoma. Med Sci. 9(4):63. doi:10.3390/medsci9040063.
   Google Scholar
• Su Q, Xu ZX, Xiong ML, Li HY, Xu MY, Luo SZ. 2022. The oncogenic miR-27a/BTG2 axis promotes obesity-associated hepatocellular carcinoma by mediating mitochondrial dysfunction. Neoplasma. 69(4):820–831. doi:10.4149/neo_2022_211227N1837.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1):W98–W102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 31(2):455–461. doi:10.1002/jcc.21334.
   PubMed Web of Science ®Google Scholar
• Voss DM, Sloan A, Spina R, Ames HM, Bar EE. 2020. The alternative splicing factor, MBNL1, inhibits glioblastoma tumor initiation and progression by reducing hypoxia-induced stemness. Cancer Res. 80(21):4681–4692. doi:10.1158/0008-5472.CAN-20-1233.
   PubMed Web of Science ®Google Scholar
• Wang XD. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922–2933.
   PubMed Web of Science ®Google Scholar
• Winslow S, Scholz A, Rappl P, Brauß TF, Mertens C, Jung M, Weigert A, Brüne B, Schmid T. 2019. Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation. PLOS One. 14(1):e0209694. doi:10.1371/journal.pone.0209694.
   PubMed Web of Science ®Google Scholar
• Yan Z, Jiang J, Li F, Yang W, Xie G, Zhou C, Xia S, Cheng Y. 2015. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin. Oncol Rep. 33(4):1791–1798. doi:10.3892/or.2015.3807.
   PubMed Web of Science ®Google Scholar
• Yang D, Wang T, Long M, Li P. 2020. Quercetin: its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev. 2020:8825387. doi:10.1155/2020/8825387.
   PubMed Web of Science ®Google Scholar
• Yang H, Bao YY, Jin FF, Jiang CH, Wei ZH, Liu ZL, Xu YP. 2022. Ceruloplasmin inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells and is negatively regulated by miR-543. Nucleosides Nucleotides Nucleic Acids. 41(5–6):474–488. doi:10.1080/15257770.2022.2052314.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Ohno Y, Egawa T, Ohashi K, Ito R, Ortuste Quiroga HP, Yamashita T, Goto K. 2020. MBNL1-associated mitochondrial dysfunction and apoptosis in C2C12 myotubes and mouse skeletal muscle. Int J Mol Sci. 21(17):6376. doi:10.3390/ijms21176376.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Wu W, Wang F, Liu X, Shui G, Nie C. 2017. Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion. Cell Death Dis. 8(10):e3151. doi:10.1038/cddis.2017.559.
   PubMedGoogle Scholar
• Zhu B, Zhi Q, Xie Q, Wu X, Gao Y, Chen X, Shi L. 2019. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma. J Trace Elem Med Biol. 56:52–59. doi:10.1016/j.jtemb.2019.07.009.
   PubMed Web of Science ®Google Scholar